Transfusion-acquired HIV infection among immunocompromised hosts. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Transfusion-acquired HIV infection among immunocompromised hosts.

Hamatol Bluttransfus. 1987;31:410-3. Unique Identifier : AIDSLINE MED/88168122
Marlink R; Anderson K; Essex M; Groopman J

Abstract: This survey suggests that HIV infection in immunocompromised hosts is characterized by a high attack rate, short incubation time to clinical sequelae, and WB and RIP seropositivity which may precede evidence of antibodies by ELISA by weeks or months. The functional properties of patients' serum antibodies, such as neutralizing activity against HIV in vitro, may correlate with clinical course.
Keywords: Acquired Immunodeficiency Syndrome/ETIOLOGY/IMMUNOLOGY/ *TRANSMISSION Antibodies, Viral/ANALYSIS Blood Transfusion/*ADVERSE EFFECTS Human Immune Tolerance Neoplasms/COMPLICATIONS/IMMUNOLOGY/THERAPY Time Factors JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/etiology/immunology/KWDtransmissionantibodies,viral/analysisbloodtransfusion/KWDadverseeffectshumanimmunetoleranceneoplasms/complications/immunology/therapytimefactorsjournalarticle
880730
M8870452

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .